Age 18-80 years old;
IFG: 5.6mmol/L (100mg/dl)=FPG<7.0mmol/L (126mg/dl), or IGT: 7.8mmol/L (140mg/dl)=OGTT 2-h PG<11.1mmol/L (200mg/dl), or HbA1C 5.7-6.4% (39-47mmol/mol);
2.6mmol/L (100mg/dl)=LDL-C=5.2mmol/L (200mg/dl), and TG<5.7mmol/L (500mg/dl);
130mmHg=SBP<180mmHg, or 80mmHg=DBP<110mmHg or ongoing anti-hypertensive therapy;
Patients volunteered for the study and signed informed consent.

NCT03532620_inc_T1
Person
Age
NCT03532620_inc_T2
Value
18-80 years old
NCT03532620_inc_T3
Condition
IFG
NCT03532620_inc_T4
Value
5.6mmol/L
NCT03532620_inc_T5
Measurement
FPG
NCT03532620_inc_T6
Value
100mg/dl
NCT03532620_inc_T7
Value
<7.0mmol/L
NCT03532620_inc_T8
Value
126mg/dl
NCT03532620_inc_T9
Condition
IGT
NCT03532620_inc_T10
Value
7.8mmol/L
NCT03532620_inc_T11
Value
140mg/dl
NCT03532620_inc_T12
Measurement
OGTT 2-h PG
NCT03532620_inc_T13
Measurement
HbA1C
NCT03532620_inc_T14
Value
5.7-6.4%
NCT03532620_inc_T15
Value
39-47mmol/mol
NCT03532620_inc_T16
Value
<11.1mmol/L
NCT03532620_inc_T17
Value
200mg/dl
NCT03532620_inc_T18
Value
2.6mmol/L
NCT03532620_inc_T19
Value
100mg/dl
NCT03532620_inc_T20
Measurement
LDL-C
NCT03532620_inc_T21
Value
5.2mmol/L
NCT03532620_inc_T22
Value
200mg/dl
NCT03532620_inc_T23
Measurement
TG
NCT03532620_inc_T24
Value
<5.7mmol/L
NCT03532620_inc_T25
Value
500mg/dl
NCT03532620_inc_T26
Value
130mmHg
NCT03532620_inc_T27
Measurement
SBP
NCT03532620_inc_T28
Value
<180mmHg
NCT03532620_inc_T29
Value
80mmHg=
NCT03532620_inc_T30
Measurement
DBP
NCT03532620_inc_T31
Value
<110mmHg
NCT03532620_inc_T32
Temporal
ongoing
NCT03532620_inc_T33
Procedure
anti-hypertensive therapy